Latest
Recent Articles
Latest
Oxytocin's neuroprotective role against GLP-1-associated bone loss in postmenopausal women
Postmenopausal women using GLP-1 agonists for weight loss may face accelerated bone loss. Oxytocin, a neuropeptide with osteoanabolic properties
Read Articlefemale reproductive health
Kisspeptin as a neuroendocrine strategy to counter GLP-1-induced menstrual disruptions in women
GLP-1 agonists like semaglutide and tirzepatide can disrupt menstrual cycles by suppressing hypothalamic kisspeptin. Research explores kisspeptin and
female peptides bone density
Oxytocin vs. GLP-1 for Female Weight Loss: Bone Health Divergence
Oxytocin and GLP-1 agonists suppress appetite differently, with divergent bone health outcomes in women. Oxytocin signals directly on bone cells;...
fertilité féminine
Kisspeptine et régulation hormonale féminine : au-delà des GLP-1
La kisspeptine, peptide méconnu de l'hypothalamus, orchestre fertilité et métabolisme féminin bien au-delà des GLP-1. Découvrez son rôle essentiel dans...